1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anti-Infective Drug News OCTOBER 2016

Anti-Infective Drug News OCTOBER 2016

  • October 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - MMV-Led Initiatives Set To Bear Fruit
Industry Brief - The Medicines Company Secures BARDA Grant To Develop Antibiotics Targeting Drug-Resistant Infections
Industry Brief - UN Declaration Signed To Combat Antimicrobial Resistance
Industry Brief - Apotex Relaunches Ofloxacin Otic Solution
Industry Brief - Emergent Awarded BARDA NuThrax Development Contract
Industry Brief - First Patient Dosed In Eravacycline Phase III IGNITE4 Study
Industry Brief - Spero Secures Award To Develop Combination Therapy For MDR Gram-Negative Pathogens
Industry Brief - Enrolment Begins In MOB-015 Phase III Trial For Onychomycosis
Industry Trend Analysis - Novel Antifungal Target Will Reward Scynexis
Industry Brief - FDA Grants QIDP/Fast Track Designations To VT-1161 In RVVC
Industry Brief - Paediatric TB Product Launched In Kenya
Industry Trend Analysis - Country-Specific Strategy Integral To Commercialising Dengue Treatments
Industry Brief - Batavia Secures Grant To Develop Rotavirus Vaccine
Industry Brief - Sanofi Pasteur Secures BARDA Grants To Advance Phase II Development Of ZPIV
Industry Brief - Vaxfectin Phase II Trial Initiated In HSV-2 Infection
Industry Brief - DoH Recommends Re-Addition Of Zostavax Shingles Vaccine In UK Immunisation Programme
Industry Brief - Protein Sciences/Avanzcare Pursue Influenza Vaccines In MENA Region
Industry Brief - NewLink Secures BARDA Contract For Investigational Ebola Zaire Vaccine
Industry Brief - Genocea's GEN-003 Exhibits Significant Reduction Of Viral Shedding In Phase IIb Trial
Industry Brief - CHMP Adopts Positive Opinion On CMV-CTL In Impaired Immune System
Industry Trend Analysis - Flublok Safety Advantages Will Carve Out Market Niche
Industry Trend Analysis - Merck's Transplant Antiviral Will Help Improve Standard Of Care
Industry Brief - BN Initiates Phase II MVA-BN RSV Trial
Industry Brief - Pfizer Awarded Grant To Conduct Phase I/II Trial Against GBS Infection
Industry Brief - Teva Launches Abacavir+Lamivudine
Industry Trend Analysis - Niche HIV Adjunctive Success Will Open Up Broader Potential For Napo
Industry Trend Analysis - Efficacy Against Drug Resistant Malaria A Major Advantage For Novartis
Industry Brief - FDA Grants Fast Track Designation To Sanaria PfSPZ Malaria Vaccine
Industry Trend Analysis - Gilead Partnership Will Enhance VL 2020 Target
Industry Brief - ANI Launches Erythromycin Ethylsuccinate
Industry Brief - FDA Accepts Avycaz sNDA For Review
Industry Brief - Selexis/IAVI Expand Collaboration To Develop High-Performance Research Cell Banks
Industry Brief - MicuRx Closes USD55mn Financing For Antibiotic, MRX-I, Development
Industry Trend Analysis - Narrow Focus On Oncology Increases Risk For Medivir
Industry Brief - Vedanta Granted European Patent Covering Microbiome Therapeutics
Industry Brief - AbbVie's G/P HCV Regimen Gains FDA Breakthrough Therapy Designation
Industry Trend Analysis - Gilead's Defence Strategy Will Overcome Sofosbuvir European Patent Setback
Industry Brief - ContaVir Advances CMX157 Dose-Escalation Phase IIa HBV Study
Industry Brief - First Patient Dosed In Phase II LIMT HDV Study

Table Of Contents

Anti-Infective Drug News OCTOBER 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. In this report, ...

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19

  • $ 4995
  • Industry report
  • November 2016
  • by GBI Research

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19 Summary Cancer vaccines are being ...

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance

  • $ 4995
  • Industry report
  • January 2017
  • by GBI Research

Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance Summary The antibacterial drug market covers ...


Download Unlimited Documents from Trusted Public Sources

Chemotherapy Market in the US

  • February 2017
    9 pages
  • Chemotherapy  

  • United States  

View report >

Therapy and Hormone Market in China

  • February 2017
    9 pages
  • Therapy  

    Hormone  

    Smoking Statist...  

  • China  

View report >

Therapy Market in the US

  • February 2017
    9 pages
  • Therapy  

  • United States  

View report >

Related Market Segments :

Infectious Disease

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.